Please login to the form below

Not currently logged in


This page shows the latest ROI news and features for those working in and with pharma, biotech and healthcare.

The new basics

The new basics

Using techniques such as Marketing Due Diligence, they substantiate their promises of risk-adjusted ROI far better than most of the industry.

Latest news

  • Pharma is ‘getting lower returns on R&D’ Pharma is ‘getting lower returns on R&D’

    Four second-tier companies added to the survey in 2014 - AbbVie, Celgene, Biogen and Gilead - had an average ROI of 11.9%, almost four times the industry average this but still

  • The new science of content marketing The new science of content marketing

    Driving positive results. Getting the best ROI out of your content and creative decisions is something that should begin when you are planning and strategising around what content you should make.

  • The potential of programmatic The potential of programmatic

    And those learnings are happening in real time, which means a campaign can be optimised throughout its duration, potentially increasing ROI.

  • Key Accounts Key Accounts

    Within this framework three key elements are measured - effective use of resources, ie the individual ROI for key channels; the effectiveness of behaviours, notably selling and influencing skills; and the degree ... Within a profit and loss framework we

  • Sweet emotion Sweet emotion

    I know from personal experience of A/B tests that a well-executed brand idea can dramatically impact the effectiveness of a communication - pulling seven times the response; increasing ROI by

More from news
Approximately 1 fully matching, plus 137 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 41 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....